Pentadeca Arginate (PDA)
Pentadeca Arginate (PDA). A BPC-157-derived peptide marketed as a more stable alternative. It has almost no published research of its own.
How it works. Presumed to share BPC-157's proposed actions: new blood-vessel growth via VEGFR2, nitric-oxide modulation, and faster tendon and gut healing in animals.
What the research supports. 1 graded claims. Strongest: Tissue-repair claims extrapolated from BPC-157 animal studies (preclinical).
Side effects and interactions. 0 medication interactions listed. Serious: Unregulated products with unknown purity.
Stacking. Avoid combining with Active cancer.
Common forms. Available as Subcutaneous injection (compounded), Oral (compounded).
Community. Experiences from people who have tried Pentadeca Arginate (PDA). Anecdotes are not medical advice.
Pentadeca Arginate (PDA). A BPC-157-derived peptide marketed as a more stable alternative. It has almost no published research of its own.
What it is
Sold since 2024 as a stabilized relative of BPC-157, mainly after compounding pharmacies lost access to BPC-157. Its claims rest on BPC-157's animal research, not studies of PDA itself.
Also called
How it works
Presumed to share BPC-157's proposed actions: new blood-vessel growth via VEGFR2, nitric-oxide modulation, and faster tendon and gut healing in animals.
Pathways
- VEGFR2 signaling (presumed)
- Nitric oxide system (presumed)
Effects
- +Tissue repair (extrapolated from BPC-157) supports
What the research supports
Strong: consistent results across large trials or meta-analyses. Moderate: several trials, mostly positive. Limited: small or mixed studies. Preclinical: animal or cell research only.
Side effects & interactions
Common side effects
- Injection-site irritation
Serious
- Unregulated products with unknown purity
No notable medication interactions listed.
Check any supplement–medication combination with your pharmacist before starting.
Combines with
Avoid combining
- Active cancerNew blood-vessel growth is undesirable when tumors are present.
Common forms
- Subcutaneous injection (compounded)
- Oral (compounded)
Discussion
Loading discussion…